To determine whether coronary artery bypass grafting (CABG) with complete revascularization improves survival in patients with multivessel disease (MVD) over CABG with incomplete revascularization, we performed a meta-analysis of adjusted (but not unadjusted) risk estimates from observational studies. Databases including MEDLINE and EMBASE were searched through October 2013 using Web-based search engines (PubMed, OVID). Eligible studies were observational studies of complete-versus incomplete-revascularization CABG enrolling ≥100 patients with MVD in each treatment arm and reporting an adjusted hazard ratio for follow-up mortality. Mixed-effects meta-regression analyses were performed to determine whether the effects of complete-revascularization CABG on survival were modulated by the prespecified factors. Fourteen observational studies enrolling 30 389 patients were identified and included. A pooled analysis demonstrated a statistically significant 37% reduction in follow-up mortality with complete-relative to incomplete-revascularization CABG (hazard ratio, 0.63; 95% confidence interval, 0.53-0.75; P < 0.00001). Although meta-regression coefficients were not statistically significant for mean follow-up duration and age and proportion of men and patients undergoing off-pump CABG, that for proportion of patients with diabetes was significantly negative (P = 0.03), which would indicate that as patients with diabetes increase, complete-revascularization CABG is more beneficial for survival. In conclusion, complete-revascularization CABG appears to improve survival over incomplete-revascularization CABG in patients with MVD.
INTRODUCTION
Since the Coronary Artery Surgery Study [1] demonstrated that more complete revascularization (i.e. bypassing ≥3 vessels versus 1 or 2) was associated with improved survival among patients with triplevessel disease and severe preoperative angina, it has been perennially believed that complete revascularization is superior to incomplete revascularization in patients with multivesssel disease (MVD) undergoing coronary artery bypass grafting (CABG). To the best of our knowledge and belief, however, no randomized controlled trial has ever proved this hypothesis to date. Further, in a recent large observational study enrolling 9000 patients (see Supplementary material, Reference [E1]), reasonable incomplete-revascularization CABG of the circumflex or right coronary artery territory, in the presence of a left internal mammary artery-to-left anterior descending artery bypass, did not adversely affect long-term survival in patients with MVD. Furthermore, a more recent study enrolling >6000 patients (Supplementary material, Reference [E2]) showed that completerevascularization CABG did not seem to improve long-term survival in older patients contrary to what was observed in <60-year old patients. Thus, the appropriate role of complete-revascularization CABG in MVD populations remains unclear. To determine whether complete-revascularization CABG improves survival in patients with MVD over incomplete-revascularization CABG, we performed a meta-analysis of adjusted (but not unadjusted) risk estimates from observational studies.
METHODS
To identify all observational studies of patients with MVD enrolled for complete-versus incomplete-revascularization CABG, databases including MEDLINE and EMBASE were searched through October 2013 using Web-based search engines (PubMed, OVID). Keywords included coronary artery bypass, complete, incomplete and revascularization. Studies considered for inclusion met the following criteria: the design was an observational study enrolling ≥100 patients in each treatment arm; the study population comprised patients with MVD; patients were assigned to complete-versus incompleterevascularization CABG; and outcomes included an adjusted hazard ratio (HR) (alternatively odds ratio or relative risk) for follow-up mortality. Study-specific estimates were combined using inverse variance-weighted averages of logarithmic HRs in the randomeffects model. Sensitivity analyses were performed to assess the contribution of each study to the pooled estimate by excluding individual studies one at a time and recalculating the pooled HR estimates for the remaining studies. Publication bias was assessed graphically using a funnel plot and mathematically using an adjusted rank-correlation [2] and linear regression test [3] . We also performed the non-parametric 'trim and fill' procedure [4] to further assess the possible effect of publication bias in our meta-analysis. Mixedeffects (unrestricted maximum likelihood) meta-regression analyses were performed to determine whether the effects of completerevascularization CABG on survival were modulated by the prespecified factors: i.e. the mean follow-up duration (year) and age (year); as well as the proportion (%) of men, patients with hypertension and diabetes and those undergoing off-pump CABG. All analyses were conducted using Review Manager version 5.2 (Nordic Cochrane Centre, Copenhagen, Denmark) and Comprehensive Meta-Analysis Version 2 (Biostat, Englewood, NJ, USA).
RESULTS
Our exhaustive search identified 14 observational studies of complete-versus incomplete-revascularization CABG [E1-14] (Table 1) ) that reported an HR for cardiac death; combining the remaining 12 studies generated a still statistically significant result favouring complete-revascularization CABG (HR, 0.65; 95% CI, 0.54-0.78; P < 0.00001). In general, exclusion of any single study from the analysis did not substantively alter the overall result of our analysis (see Supplementary Fig. E1 ). To assess publication bias, we generated a funnel plot of the logarithm of effect size versus the precision (reciprocal of standard error) for each study (see Supplementary Fig. E2 ). Because of significant funnel plot asymmetry (P = 0.02 and 0.002 by the adjusted rank-correlation and linear regression test, respectively), we undertook a sensitivity analysis using the trim and fill method [4] . The five imputed studies produce a symmetrical funnel plot (see Supplementary  Fig. E2 ), and the pooled analysis incorporating the five hypothetical studies continued to show a statistically significant benefit of complete-over incomplete-revascularization CABG with regard to survival (HR, 0.73; 95% CI, 0.61-0.86). Although metaregression coefficients were not statistically significant for the mean follow-up duration (P = 0.54) and age (P = 0.90), as well as the proportion of men (P = 0.79), patients with hypertension (P = 0.40) and those undergoing off-pump CABG (P = 0.35), that for the proportion of patients with diabetes was significantly negative (P = 0.03; see Supplementary Fig. E3 ).
DISCUSSION
The results of our analysis suggest that complete-revascularization CABG may improve survival over incomplete-revascularization CABG, which was robust in sensitivity analyses. Although the statistical tests indicated funnel plot asymmetry, the trim and fill method [4] adjusting for the publication bias still showed a significant benefit of complete-revascularization CABG. One of meta-regression analyses would indicate that as proportion of patients with diabetes increases, complete-revascularization CABG is more beneficial for survival. Because patients with diabetes have more diffuse coronary disease with a 2-fold higher rate of total occlusions and a tendency towards more distal disease [5] [7] [8] [9] . In the present metaanalysis, however, even including these studies (Supplementary material, Reference [E1, E4]) showed a benefit of complete-over incomplete-revascularization CABG with regard to survival. To reduce the effect of treatment-selection bias and potential confounding, we strictly abstracted (then combined in a metaanalysis) adjusted (but not unadjusted) risk estimates from observational studies. However, potential biases are likely to be greater for observational studies compared with randomized trials; so results should always be interpreted with caution when they are included in reviews and meta-analyses [10] .
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